Nuevo método cuantitativo para evaluar el rango de hospedadores de bacteriófagos desarrollado en colaboración entre Proteon Pharmaceuticals y el Instituto de Biología Médica PAS
Scientists from Proteon Pharmaceuticals S.A., in collaboration with researchers from the Institute of Medical Biology Polish Academy of Sciences, have developed a new quantitative method for
Proteon Pharmaceuticals publica una nueva investigación sobre la arquitectura de las espículas de la cola de los bacteriófagos
Our researchers have recently published their latest article in Frontiers in Microbiology, a paper titled “Revisiting Phage Tail Spike Architecture: Evidence for Undetected Receptor-Binding Proteins
The EU Approves BAFASAL® – First Bacteriophage-Based Zootechnical Feed Additive for Poultry
Proteon Pharmaceuticals is pleased to confirm that BAFASAL®, its pioneering bacteriophage-based feed additive, has received full regulatory approval from the European Union for use in
BAFASAL® Moves Closer to EU Authorisation
Following the Standing Committee on Plants, Animals, Food and Feed (PAFF Committee) recent meeting in Brussels, Proteon Pharmaceuticals is pleased to share a significant development
Oportunidades y retos de la terapia con fagos en la acuicultura moderna
A 2020 study published in Viruses (MDPI), titled “Growing Trend of Fighting Infections in Aquaculture Environment – Opportunities and Challenges of Phage Therapy”, provides a
Solución innovadora en el diagnóstico APEC: Resultados de las últimas investigaciones
A team of scientists from Proteon Pharmaceuticals, the Biobank Lodz, and the University of Agriculture in Cracow has developed an innovative method for identifying strains